Literature DB >> 26554878

Transparency in a Pediatric Quality Improvement Collaborative: A Passionate Journey by NPC-QIC Clinicians and Parents.

Stacey L Lihn1, John D Kugler2, Laura E Peterson3, Carole M Lannon4, Diane Pickles1, Robert H Beekman5.   

Abstract

Transparency-sharing data or information about outcomes, processes, protocols, and practices-may be the most powerful driver of health care improvement. In this special article, the development and growth of transparency within the National Pediatric Cardiology Quality Improvement Collaborative is described. The National Pediatric Cardiology Quality Improvement Collaborative transparency journey is guided by equal numbers of clinicians and parents of children with congenital heart disease working together in a Transparency Work Group. Activities are organized around four interrelated levels of transparency (individual, organizational, collaborative, and system), each with a specified purpose and aim. A number of Transparency Work Group recommendations have been operationalized. Aggregate collaborative performance is now reported on the public-facing web site. Specific information that the Transparency Work Group recommends centers provide to parents has been developed and published. Almost half of National Pediatric Cardiology Quality Improvement Collaborative centers participated in a pilot of transparently sharing their outcomes achieved with one another. Individual centers have also begun successfully implementing recommended transparency activities. Despite progress, barriers to full transparency persist, including health care organization concerns about potential negative effects of disclosure on reputation and finances, and lack of reliable definitions, data, and reporting standards for fair comparisons of centers. The National Pediatric Cardiology Quality Improvement Collaborative's transparency efforts have been a journey that continues, not a single goal or destination. Balanced participation of clinicians and parents has been a critical element of the collaborative's success on this issue. Plans are in place to guide implementation of additional transparency recommendations across all four levels, including extension of the activities beyond the collaborative to support transparency efforts in national cardiology and cardiac surgery societies.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Congenital Heart Disease; Hypoplastic Left Heart Syndrome; Public Reporting; Quality Improvement Collaborative; Transparency

Mesh:

Year:  2015        PMID: 26554878     DOI: 10.1111/chd.12314

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  4 in total

1.  Accelerating Improvement in Children's Healthcare Through Quality Improvement Collaboratives: A Synthesis of Recent Efforts.

Authors:  Michael Terao; James M Hoffman; Richard J Brilli; Amanda Finch; Kathleen E Walsh; Maitreya Coffey
Journal:  Curr Treat Options Pediatr       Date:  2019-05-04

Review 2.  Recent innovations in perfusion and cardiopulmonary bypass for neonatal and infant cardiac surgery.

Authors:  David Sturmer; Claude Beaty; Sean Clingan; Eric Jenkins; Whitney Peters; Ming-Sing Si
Journal:  Transl Pediatr       Date:  2018-04

Review 3.  Using a network organisational architecture to support the development of Learning Healthcare Systems.

Authors:  Maria T Britto; Sandra C Fuller; Heather C Kaplan; Uma Kotagal; Carole Lannon; Peter A Margolis; Stephen E Muething; Pamela J Schoettker; Michael Seid
Journal:  BMJ Qual Saf       Date:  2018-02-05       Impact factor: 7.035

4.  Health Care Policy and Congenital Heart Disease: 2020 Focus on Our 2030 Future.

Authors:  Devyani Chowdhury; Jonathan N Johnson; Carissa M Baker-Smith; Robert D B Jaquiss; Arjun K Mahendran; Valerie Curren; Aarti Bhat; Angira Patel; Audrey C Marshall; Stephanie Fuller; Bradley S Marino; Christina M Fink; Keila N Lopez; Lowell H Frank; Mishaal Ather; Natalie Torentinos; Olivia Kranz; Vivian Thorne; Ryan R Davies; Stuart Berger; Christopher Snyder; Arwa Saidi; Kenneth Shaffer
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.